Chronic Administration of Diosmectite (SMECTA®) in Subjects With Chronic Diarrhoea
Status:
Completed
Trial end date:
2017-05-09
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to assess the concentration of elemental impurities in
blood and urine after chronic administration of Smecta® in subjects with chronic functional
diarrhoea. For exploratory purposes, the potential effects of diosmectite on bowel microbiote
composition will be investigated.